ULTRAMOP CAP 10MG DIN 00646237
Health Canada record
| Active ingredient(s) | METHOXSALEN 10 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D05BA02 METHOXALEN, SYSTEMIC |
| Original market date | 31-Dec-1985 |
| Current status date | 28-Jul-2011 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOXSALEN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02406233 | UVADEX | THERAKOS LLC | Solution | METHOXSALEN 20 MCG | Marketed |
| 01946374 | OXSORALEN CAP 10MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Capsule | METHOXSALEN 10 MG | Cancelled Post Market |
| 01907476 | OXSORALEN LOT 10MG/ML | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Lotion | METHOXSALEN 10 MG | Cancelled Post Market |
| 00252654 | OXSORALEN-ULTRA CAP 10MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Capsule | METHOXSALEN 10 MG | Cancelled Post Market |
| 00698059 | ULTRA MOP LOTION 1% | CANDERM G.P. | Liquid | METHOXSALEN 1 % | Cancelled Post Market |
International API supply for METHOXSALEN
2 active FDA Drug Master Files.
Request a quote for ULTRAMOP CAP 10MG